Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

This article reviews current pump and continuous glucose monitoring therapy and what will be required to integrate these systems into closed-loop control. Issues with sensor accuracy, lag time, and calibration are discussed as well as issues with insulin pharmacodynamics, which result in a delayed onset of insulin action in a closed-loop system. A stepwise approach to closed-loop therapy is anticipated, where the first systems will suspend insulin delivery based on actual or predicted hypoglycemia. Subsequent systems may control to range, limiting the time spent in hyperglycemia by mitigating the effects of a missed food bolus or underestimate of consumed carbohydrates, while minimizing the risk of hypoglycemia.

[1]  Göran Stemme,et al.  Novel Microneedle Patches for Active Insulin Delivery are Efficient in Maintaining Glycaemic Control: An Initial Comparison with Subcutaneous Administration , 2007, Pharmaceutical Research.

[2]  Å. Lernmark,et al.  Regulation of glutamic acid decarboxylase diabetes autoantigen expression in highly purified isolated islets from Macaca nemestrina. , 1993, Endocrinology.

[3]  D. Gough,et al.  Application of Chronic Intravascular Blood Glucose Sensor in Dogs , 1990, Diabetes.

[4]  P Wach,et al.  Simulation studies on neural predictive control of glucose using the subcutaneous route. , 1998, Computer methods and programs in biomedicine.

[5]  Bruce Buckingham,et al.  Response to nocturnal alarms using a real-time glucose sensor. , 2005, Diabetes technology & therapeutics.

[6]  E Renard,et al.  [From external to implantable insulin pump, can we close the loop?]. , 2002, Diabetes & metabolism.

[7]  Matthew Page,et al.  Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. , 2010, The Cochrane database of systematic reviews.

[8]  W. Tamborlane,et al.  Epipen as an alternative to glucagon in the treatment of hypoglycemia in children with diabetes. , 2001, Diabetes care.

[9]  C. Clar,et al.  Self-monitoring of blood glucose in type 2 diabetes: systematic review. , 2010, Health technology assessment.

[10]  Howard Wolpert,et al.  Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes , 2009, Diabetes Care.

[11]  R. Tanenberg,et al.  Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  D. B. Keenan,et al.  Delays in Minimally Invasive Continuous Glucose Monitoring Devices: A Review of Current Technology , 2009, Journal of diabetes science and technology.

[13]  S. Mudaliar,et al.  Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. , 1999, Diabetes care.

[14]  Roy Beck,et al.  Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real‐time continuous glucose monitor (the FreeStyle Navigator) , 2008, Pediatric diabetes.

[15]  O. Kämpe,et al.  Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion , 1992, Diabetologia.

[16]  B. Bequette.  Nonlinear control of chemical processes: a review , 1991 .

[17]  J. Rygaard,et al.  Dependence of Antigen Expression on Functional State of β-Cells , 1990, Diabetes.

[18]  G. Borsboom,et al.  Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison , 2008, Pediatric diabetes.

[19]  Ilya V. Kolmanovsky,et al.  Predictive energy management of a power-split hybrid electric vehicle , 2009, 2009 American Control Conference.

[20]  R. Brazg,et al.  Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System , 2007, Diabetes Care.

[21]  W. Tamborlane,et al.  Insulin-infusion pump for diabetes. , 1979, The New England journal of medicine.

[22]  Jeanette S. Andrews,et al.  Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. , 2009, The Journal of pediatrics.

[23]  Bruce A Buckingham,et al.  Accuracy of the modified Continuous Glucose Monitoring System (CGMS) sensor in an outpatient setting: results from a diabetes research in children network (DirecNet) study. , 2005, Diabetes technology & therapeutics.

[24]  Pratik Choudhary,et al.  Continuous glucose monitoring and type 1 diabetes. , 2009, The New England journal of medicine.

[25]  H Peter Chase,et al.  Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. , 2004, Pediatrics.

[26]  R. Beck,et al.  Continuous glucose monitoring in children with type 1 diabetes. , 2007, The Journal of pediatrics.

[27]  N. Simpson,et al.  A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[28]  B.W. Bequette,et al.  Computationally efficient neural predictive control based on a feedforward architecture , 2006, 2006 American Control Conference.

[29]  J. Leahy,et al.  Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas , 2008 .

[30]  Efstratios N. Pistikopoulos,et al.  Model-based blood glucose control for type 1 diabetes via parametric programming , 2006, IEEE Transactions on Biomedical Engineering.

[31]  T. Jones,et al.  Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial , 2009, Diabetologia.

[32]  Eyal Dassau,et al.  Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring , 2010, Diabetes Care.

[33]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[34]  I. Hirsch,et al.  Practical aspects of real-time continuous glucose monitoring. , 2009, Diabetes technology & therapeutics.

[35]  R.S. Parker,et al.  A model-based algorithm for blood glucose control in Type I diabetic patients , 1999, IEEE Transactions on Biomedical Engineering.

[36]  G. Lippi,et al.  Continuous glucose monitoring and type 1 diabetes. , 2009, The New England journal of medicine.

[37]  S. Garg,et al.  Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. , 2004, Diabetes care.

[38]  Roman Hovorka,et al.  Multicentric, randomized, controlled trial to evaluate blood glucose control by the model predictive control algorithm versus routine glucose management protocols in intensive care unit patients. , 2006, Diabetes care.

[39]  Roy W Beck,et al.  Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals , 2010, Diabetes Care.

[40]  Jens Sandahl Christiansen,et al.  Continuous glucose monitoring in interstitial subcutaneous adipose tissue and skeletal muscle reflects excursions in cerebral cortex. , 2005, Diabetes.

[41]  G. Steil,et al.  Modeling beta-cell insulin secretion--implications for closed-loop glucose homeostasis. , 2003, Diabetes technology & therapeutics.

[42]  Eric Renard,et al.  Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy. , 2002, Current opinion in pharmacology.

[43]  L. Schaupp,et al.  On‐line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[44]  F. El-Khatib,et al.  Pharmacodynamics and stability of subcutaneously infused glucagon in a type 1 diabetic Swine model in vivo. , 2007, Diabetes technology & therapeutics.

[45]  B. Bequette,et al.  Process Control: Modeling, Design and Simulation , 2003 .

[46]  Michael Brownlee,et al.  The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes , 2007, Diabetes Care.

[47]  Peter C Laussen,et al.  Real-Time Continuous Glucose Monitoring in Pediatric Patients During and After Cardiac Surgery , 2006, Pediatrics.

[48]  O. Khalil,et al.  Non-invasive glucose measurement technologies: an update from 1999 to the dawn of the new millennium. , 2004, Diabetes technology & therapeutics.

[49]  J. Palmer,et al.  The functional state of the beta cell modulates IL-1 and TNF-induced cytotoxicity. , 1993, Lymphokine and cytokine research.

[50]  B. Wayne Bequette,et al.  Computationally efficient neural predictive control based on a feedforward architecture , 2006 .

[51]  J. Sturis,et al.  Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. , 2004, Diabetes.

[52]  Howard Wolpert,et al.  Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). , 2008, Diabetes technology & therapeutics.

[53]  D. Pipeleers,et al.  Glucose regulation of the autoantigen GAD65 in human pancreatic islets. , 1992, Journal of Clinical Endocrinology and Metabolism.

[54]  J. Mellado-Gil,et al.  Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines , 2005, Biological Procedures Online.

[55]  L. Zimmerman.  Aerosol infectivity of Legionella pneumophila. , 1979, The New England journal of medicine.

[56]  D. B. Keenan,et al.  Accuracy of a New Real-Time Continuous Glucose Monitoring Algorithm , 2010, Journal of diabetes science and technology.

[57]  E. Cummins,et al.  Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. , 2010, Health technology assessment.

[58]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[59]  O. Kämpe,et al.  High-Glucose Stimulation of 64,000-Mr Islet Cell Autoantigen Expression , 1989, Diabetes.

[60]  Michael Brownlee,et al.  Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. , 2006, JAMA.

[61]  J. Palmer,et al.  Metabolic state of the pancreas affects end-point titre in the islet cell antibody assay , 1991, Diabetologia.

[62]  J. Mellado-Gil,et al.  High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes. , 2004, The Journal of endocrinology.

[63]  Bruce A Buckingham,et al.  Evaluation of factors affecting CGMS calibration. , 2006, Diabetes technology & therapeutics.

[64]  F. Cameron,et al.  Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. , 2009, Diabetes technology & therapeutics.

[65]  F. Doyle,et al.  Detection of a Meal Using Continuous Glucose Monitoring , 2008, Diabetes Care.

[66]  G. Steil,et al.  Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes , 2006, Diabetes.

[67]  Bruce A Buckingham,et al.  Lack of accuracy of continuous glucose sensors in healthy, nondiabetic children: results of the Diabetes Research in Children Network (DirecNet) accuracy study. , 2004, The Journal of pediatrics.

[68]  R. Beck,et al.  FreeStyle Navigator Continuous Glucose Monitoring System Use in Children With Type 1 Diabetes Using Glargine-Based Multiple Daily Dose Regimens , 2008, Diabetes Care.

[69]  Å. Lernmark,et al.  Functional State of the β Cell Affects Expression of Both Forms of Glutamic Acid Decarboxylase , 1994 .

[70]  F. Doyle,et al.  Prevention of Nocturnal Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump Suspension , 2010, Diabetes Care.